ArticleFrontiers in immunology2019

Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor.

Koji Ozasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.